Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: Symposium Mammographicum 2002

Review of clinical trials

RE Hendrick

  • Correspondence: RE Hendrick

Breast Cancer Res 2002, 4(Suppl 1):7 doi:10.1186/bcr530

Accesses  

  • Last 30 days: 5 accesses
  • Last 365 days: 105 accesses
  • All time: 1420 accesses